Mira Pharmaceuticals, Inc.
MIRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001904286
No open-market purchases or sales by Mira Pharmaceuticals, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $2.19M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Mira Pharmaceuticals, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 11 | 15 | +4 |
| Shares | 711.9K | 830.3K | +118.4K (+16.6%) |
| Value | $454.0K | $1.08M | +$625.4K (+137.7%) |
New holders (7)
Institutions that held Mira Pharmaceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 115,914 | $150.7K | 0.00% |
| LPL Financial LLC | 50,000 | $65.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 41,900 | $54.5K | 0.00% |
| Millennium Management LLC | 40,725 | $52.9K | 0.00% |
| Jane Street Group, LLC | 12,186 | $15.8K | 0.00% |
| Steward Partners Investment Advisory, LLC | 2,000 | $2.60K | 0.00% |
| Bank of America Corp | 88 | $114 | 0.00% |
Sold out (3)
Institutions that held Mira Pharmaceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| UBS Group AG | 29,546 | $18.8K |
| Citadel Advisors LLC | 24,396 | $16.1K |
| Bank of New York Mellon Corp | 20,001 | $12.7K |